TREVICTA

Prolonged-release suspension for injection, 525mg/2.625ml
RxActive license

Active substance (INN)

paliperidone

Pharmaceutical form

Pharmaceutical formProlonged-release suspension for injection
Strength525mg/2.625ml
PackagingUkupno 1 napunjeni injekcioni špric sa 2.625ml suspenzije za injekciju sa produženim oslobađanjem (sa 2 igle) u kartonskoj kutiji
ManufacturerJanssen Pharmaceutica N.V., Belgium
Therapeutic groupNervous system (N05AX13)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateSeptember 10, 2018

Analogs in Montenegro

13

Other medicines with the same active substance

Source: CInMED register